These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33790127)

  • 21. Incidence and course of acute coronary syndrome cases after the first wave of the COVID-19 pandemic.
    Jankowska-Sanetra J; Sanetra K; Konopko M; Kutowicz M; Synak M; Kaźmierczak P; Milewski K; Kołtowski Ł; Buszman PP
    Kardiol Pol; 2023; 81(1):22-30. PubMed ID: 36354113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Age-related differences in the management and outcome of acute coronary syndrome under the chest pain center model: a multicenter retrospective study].
    Li S; Ding X; Ye T; Cheng L; Cui C; Zhang Y; Zhu F; Jiang X; Cai L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):318-323. PubMed ID: 33834973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.
    Uemura Y; Ishikawa S; Takemoto K; Negishi Y; Tanaka A; Takagi K; Yoshioka N; Umemoto N; Inoue Y; Morishima I; Shibata N; Asano H; Ishii H; Watarai M; Murohara T;
    Clin Exp Nephrol; 2020 Apr; 24(4):339-348. PubMed ID: 31903510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global effect of COVID-19 pandemic on the rate of acute coronary syndrome admissions: a comprehensive review of published literature.
    Helal A; Shahin L; Abdelsalam M; Ibrahim M
    Open Heart; 2021 Jun; 8(1):. PubMed ID: 34083389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the COVID-19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis.
    Morishita T; Takada D; Shin JH; Higuchi T; Kunisawa S; Fushimi K; Imanaka Y
    ESC Heart Fail; 2022 Feb; 9(1):31-38. PubMed ID: 34913269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome.
    Kim BS; Eom SY; Kim SH; Hwang HK; Park JS; Kim W; Lee JW; Rha SW; Kim GY; Lim SW; Lee SH; Chae JK; Woo SI; Bae JW; Kim HJ
    Int Heart J; 2019 Nov; 60(6):1284-1292. PubMed ID: 31735782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes After Percutaneous Coronary Intervention of Acute Coronary Syndrome Complicated With Cardiopulmonary Arrest (from a Japanese Multicenter Registry).
    Numasawa Y; Sawano M; Miyata H; Ueda I; Noma S; Suzuki M; Kuno T; Kodaira M; Maekawa Y; Fukuda K; Kohsaka S
    Am J Cardiol; 2017 Apr; 119(8):1173-1178. PubMed ID: 28236456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing sensitivity and specificity of the Manchester Triage System in the evaluation of acute coronary syndrome in adult patients in emergency care: a systematic review protocol.
    Nishi FA; de Motta Maia FO; de Lopes Monteiro da Cruz DA
    JBI Database System Rev Implement Rep; 2015 Nov; 13(11):64-73. PubMed ID: 26657465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Trends and Outcomes of Percutaneous Coronary Intervention in Patients ≥70 Years of Age With Acute Coronary Syndrome (from the National Inpatient Sample Database).
    Elbadawi A; Elgendy IY; Ha LD; Mahmoud K; Lenka J; Olorunfemi O; Reyes A; Ogunbayo GO; Saad M; Abbott JD
    Am J Cardiol; 2019 Jan; 123(1):25-32. PubMed ID: 30360891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome　- An Analysis of 20,042 Patients From a Japanese Nationwide Registry.
    Sawano M; Kohsaka S; Ishii H; Numasawa Y; Yamaji K; Inohara T; Amano T; Ikari Y; Nakamura M
    Circ J; 2021 Sep; 85(10):1756-1767. PubMed ID: 34162778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced rate of admissions for acute coronary syndromes during the COVID-19 pandemic: an observational analysis from a tertiary hospital in Germany.
    Vacanti G; Bramlage P; Schymik G; Schmitt C; Luik A; Swojanowsky P; Tzamalis P
    Herz; 2020 Nov; 45(7):663-667. PubMed ID: 33026483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.
    Numasawa Y; Inohara T; Ishii H; Yamaji K; Hirano K; Kohsaka S; Sawano M; Kuno T; Kodaira M; Uemura S; Kadota K; Amano T; Nakamura M;
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):E1-E8. PubMed ID: 30467967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence and outcomes of acute coronary syndromes in a central European country: results of the CZECH-2 registry.
    Tousek P; Tousek F; Horak D; Cervinka P; Rokyta R; Pesl L; Jarkovsky J; Widimsky P;
    Int J Cardiol; 2014 May; 173(2):204-8. PubMed ID: 24602321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo.
    Watanabe Y; Miyachi H; Mozawa K; Yamada K; Oka E; Shiomura R; Sugizaki Y; Matsuda J; Nakata J; Tara S; Tokita Y; Iwasaki YK; Yamamoto T; Takano H; Shimizu W
    Intern Med; 2021 Dec; 60(23):3693-3700. PubMed ID: 34565777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement.
    Vilalta V; Asmarats L; Ferreira-Neto AN; Maes F; de Freitas Campos Guimarães L; Couture T; Paradis JM; Mohammadi S; Dumont E; Kalavrouziotis D; Delarochellière R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2523-2533. PubMed ID: 30573061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Missing" acute coronary syndrome hospitalizations during the COVID-19 era in Greece: Medical care avoidance combined with a true reduction in incidence?
    Papafaklis MI; Katsouras CS; Tsigkas G; Toutouzas K; Davlouros P; Hahalis GN; Kousta MS; Styliadis IG; Triantafyllou K; Pappas L; Tsiourantani F; Varytimiadi E; Anyfantakis ZA; Iakovis N; Grammata P; Karvounis H; Ziakas A; Sianos G; Tziakas D; Pappa E; Dagre A; Patsilinakos S; Trikas A; Lamprou T; Mamarelis I; Katsimagklis G; Karmpaliotis D; Naka K; Michalis LK
    Clin Cardiol; 2020 Oct; 43(10):1142-1149. PubMed ID: 32691901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the COVID-19 pandemic on coronary invasive procedures at two Italian high-volume referral centers.
    Fileti L; Vecchio S; Moretti C; Reggi A; Aquilina M; Balducelli M; Santarelli A; Grosseto D; Piovaccari G; Rubboli A
    J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):869-873. PubMed ID: 33009170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kwok CS; Gale CP; Kinnaird T; Curzen N; Ludman P; Kontopantelis E; Wu J; Denwood T; Fazal N; Deanfield J; de Belder MA; Mamas M
    Heart; 2020 Dec; 106(23):1805-1811. PubMed ID: 32868280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.